go back

Ciltacabtagene Autoleucel (Carvykti)

New Jersey rates for HCPCS C9098

Ciltacabtagene autoleucel, up to 100 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $12,589 · 10th–90th $135$29,5120%10%10th90th$12,589Professionalmedian $467,735 · 10th–90th $467,735$467,7350%50%100%$467,735$100.0$500.0$2.0K$10.0K$50.0K$200.0K$1.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Horizon BCBS
Setting
Facility
Modifier
Global
Typical Low
$134.90
Median
$12,589.25
Typical High
$29,512.09
Horizon BCBS
Setting
Professional
Modifier
Global
Typical Low
$467,735.14
Median
$467,735.14
Typical High
$467,735.14